Brian Harvey

Brian Harvey

Company: Biogen

Job title: Scientist

Seminars:

Understanding the Optimal Endpoints for Neurodevelopmental Disorder Symptoms & How Biomarkers Can Be Implemented to Complement Trial Design While Meeting Regulatory Standards 8:00 am - 11:00 am

Despite having seen an increase in companies entering the clinic for rare CNS and neurodevelopmental therapeutics, there are still challenges in defining objective and sensitive biological outcome measures. While these challenges remain, the development of translational and quantitative biomarkers provide promising results to support outcome measures in drug development. With more companies approaching the clinic,…Read more

day: Pre-Conference Workshop Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.